Finally, EAPB02303 drastically lowered the leukemic burden in the BM of both NPM1c and wt-NPM1 xenograft mice and significantly reduced AML-associated hepatosplenomegaly in all treated animals. Here, NPM1 is linked to acute myeloid leukemia.